ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 115 filers reported holding ENZO BIOCHEM INC in Q3 2017. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $313,000 | +146.5% | 28,325 | +86.1% | 0.12% | +200.0% |
| Q1 2017 | $127,000 | +6.7% | 15,224 | -11.5% | 0.04% | +28.1% |
| Q4 2016 | $119,000 | +108.8% | 17,209 | +52.7% | 0.03% | +128.6% |
| Q3 2016 | $57,000 | -93.6% | 11,272 | -92.5% | 0.01% | -91.5% |
| Q2 2016 | $896,000 | -34.0% | 150,022 | -49.8% | 0.16% | -15.8% |
| Q1 2016 | $1,358,000 | -32.6% | 298,557 | -33.4% | 0.20% | -9.7% |
| Q4 2015 | $2,016,000 | +655.1% | 448,047 | +431.1% | 0.22% | +734.6% |
| Q3 2015 | $267,000 | -78.4% | 84,367 | -79.3% | 0.03% | -78.5% |
| Q2 2015 | $1,235,000 | +50.6% | 407,645 | +46.6% | 0.12% | +51.2% |
| Q1 2015 | $820,000 | -44.9% | 278,031 | -17.0% | 0.08% | -43.7% |
| Q4 2014 | $1,488,000 | -25.2% | 335,090 | -13.2% | 0.14% | -17.4% |
| Q3 2014 | $1,988,000 | -23.6% | 385,968 | -22.2% | 0.17% | -16.1% |
| Q2 2014 | $2,603,000 | +34.9% | 495,804 | +6.8% | 0.20% | +60.2% |
| Q1 2014 | $1,930,000 | – | 464,044 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |